Carl Goldfischer, M.D.
Dr. Carl Goldfischer has been a member of our Board of Directors since 2020 and as our Chairman of the Board since July 2021. He previously served as an Investment Partner and Managing Director of Bay City Capital, serving as a member of the board of directors and executive committee, and is currently a member of their Scientific Advisory Board. His background includes extensive public and private investment and transaction work, as well as clinical trial development knowledge. Prior to joining Bay City Capital, Dr. Goldfischer was the Chief Financial Officer of ImClone Systems where he oversaw financial operations and strategic planning. Dr. Goldfischer has served or currently serves on the board of directors of numerous companies, including: BrainCells, EnteroMedics, Epizyme, Imara, MAP, Metabolex and Poniard. He received an M.D. with honors in Scientific Research from Albert Einstein College of Medicine, and a B.A. from Sarah Lawrence College.